Express Interest in Myosana Therapeutics

Myosana Therapeutics

Myosana Therapeutics

Myosana Therapeutics is a Seattle-based biotechnology company revolutionizing gene therapy for neuromuscular and cardiac diseases through its breakthrough non-viral delivery platform. Founded in 2018 by University of Washington experts Dr. Stan Froehner and Dr. Nick Whitehead, we're overcoming the c...

0/500

Password should be at least 8 characters long.

Cancel

We use cookies on this site to enhance your user experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies. Read our cookie policy